Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Henry Schein, Inc. (HSIC) has shown moderate revenue growth over the past 3 years, expanding from $12.6B to $13.2B (average +1.4%/yr). Net income reached $398M, reflecting earnings decline at -9%/yr on average. The net profit margin is 3%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 29.1% (low), with a -1.2pp trend over the period. With a $9B market cap and MOAT composite score of 53/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (30/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 32-year history, the company was profitable in 29 of 32 years — an excellent long-term track record
  • INCOME (30/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (53/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

51/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $3.27
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
53/100
Score: 53/100
GM 29.1% (-1.2pp)
Proven by this page
GROWTH
30/100
Rev +1.4%/yr
NI -9%/yr
Proven by this page
INCOME
30/100
Margin 3%
$13.2B
Proven by this page
Henry Schein, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $13.18B$13.18B$12.67B$12.34B$12.65B
Gross Profit $3.9B$3.84B$4.02B$3.86B$3.83B
Gross Margin 29.6%29.1%31.7%31.3%30.3%
Operating Income $742M$758M$621M$615M$747M
Net Income $398M$398M$390M$416M$538M
Net Margin 3%3%3.1%3.4%4.3%
EPS (Diluted) $3.27$3.27$3.05$3.16$3.91
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message